nodes	percent_of_prediction	percent_of_DWPC	metapath
Dutasteride—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.0836	0.118	CbGbCtD
Dutasteride—CYP3A5—Carbamazepine—epilepsy syndrome	0.0525	0.0741	CbGbCtD
Dutasteride—CYP3A5—Phenytoin—epilepsy syndrome	0.0471	0.0665	CbGbCtD
Dutasteride—CYP3A5—Phenobarbital—epilepsy syndrome	0.042	0.0592	CbGbCtD
Dutasteride—CYP3A5—Midazolam—epilepsy syndrome	0.0414	0.0584	CbGbCtD
Dutasteride—CYP3A5—Diazepam—epilepsy syndrome	0.0398	0.0562	CbGbCtD
Dutasteride—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0326	0.046	CbGbCtD
Dutasteride—CYP3A5—Valproic Acid—epilepsy syndrome	0.0314	0.0443	CbGbCtD
Dutasteride—CYP3A4—Trimethadione—epilepsy syndrome	0.0303	0.0428	CbGbCtD
Dutasteride—CYP3A4—Felbamate—epilepsy syndrome	0.0303	0.0428	CbGbCtD
Dutasteride—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0285	0.0402	CbGbCtD
Dutasteride—CYP3A4—Clonazepam—epilepsy syndrome	0.0258	0.0364	CbGbCtD
Dutasteride—CYP3A4—Clobazam—epilepsy syndrome	0.0247	0.0349	CbGbCtD
Dutasteride—CYP3A4—Rufinamide—epilepsy syndrome	0.021	0.0296	CbGbCtD
Dutasteride—CYP3A4—Carbamazepine—epilepsy syndrome	0.0205	0.0289	CbGbCtD
Dutasteride—CYP3A4—Primidone—epilepsy syndrome	0.0191	0.027	CbGbCtD
Dutasteride—CYP3A4—Phenytoin—epilepsy syndrome	0.0184	0.0259	CbGbCtD
Dutasteride—CYP3A4—Propofol—epilepsy syndrome	0.0171	0.0242	CbGbCtD
Dutasteride—CYP3A4—Acetazolamide—epilepsy syndrome	0.0164	0.0231	CbGbCtD
Dutasteride—CYP3A4—Phenobarbital—epilepsy syndrome	0.0164	0.0231	CbGbCtD
Dutasteride—CYP3A4—Midazolam—epilepsy syndrome	0.0161	0.0228	CbGbCtD
Dutasteride—CYP3A4—Diazepam—epilepsy syndrome	0.0155	0.0219	CbGbCtD
Dutasteride—CYP3A4—Zonisamide—epilepsy syndrome	0.0151	0.0214	CbGbCtD
Dutasteride—CYP3A4—Valproic Acid—epilepsy syndrome	0.0122	0.0173	CbGbCtD
Dutasteride—CYP3A4—Topiramate—epilepsy syndrome	0.011	0.0156	CbGbCtD
Dutasteride—Hyperaesthesia—Phenytoin—epilepsy syndrome	0.00138	0.00625	CcSEcCtD
Dutasteride—Tenderness—Diazepam—epilepsy syndrome	0.00137	0.0062	CcSEcCtD
Dutasteride—Sexual dysfunction—Pregabalin—epilepsy syndrome	0.00128	0.0058	CcSEcCtD
Dutasteride—Hyperaesthesia—Lamotrigine—epilepsy syndrome	0.00127	0.00577	CcSEcCtD
Dutasteride—Libido decreased—Clobazam—epilepsy syndrome	0.00126	0.00572	CcSEcCtD
Dutasteride—Breast pain—Clonazepam—epilepsy syndrome	0.00125	0.00566	CcSEcCtD
Dutasteride—Tenderness—Phenytoin—epilepsy syndrome	0.00124	0.00563	CcSEcCtD
Dutasteride—Depressed mood—Topiramate—epilepsy syndrome	0.00124	0.00561	CcSEcCtD
Dutasteride—Breast enlargement—Valproic Acid—epilepsy syndrome	0.00122	0.00555	CcSEcCtD
Dutasteride—Loss of libido—Topiramate—epilepsy syndrome	0.0012	0.00544	CcSEcCtD
Dutasteride—Sexual dysfunction—Gabapentin—epilepsy syndrome	0.00117	0.00532	CcSEcCtD
Dutasteride—Disturbance in sexual arousal—Clobazam—epilepsy syndrome	0.00116	0.00526	CcSEcCtD
Dutasteride—Breast disorder—Rufinamide—epilepsy syndrome	0.00116	0.00526	CcSEcCtD
Dutasteride—Breast pain—Lamotrigine—epilepsy syndrome	0.00114	0.00519	CcSEcCtD
Dutasteride—Breast enlargement—Pregabalin—epilepsy syndrome	0.00111	0.00502	CcSEcCtD
Dutasteride—Gynaecomastia—Diazepam—epilepsy syndrome	0.00107	0.00484	CcSEcCtD
Dutasteride—Neoplasm—Felbamate—epilepsy syndrome	0.00104	0.00474	CcSEcCtD
Dutasteride—Mental disorder—Primidone—epilepsy syndrome	0.00102	0.00461	CcSEcCtD
Dutasteride—Breast enlargement—Gabapentin—epilepsy syndrome	0.00101	0.0046	CcSEcCtD
Dutasteride—Gynaecomastia—Zonisamide—epilepsy syndrome	0.00101	0.00459	CcSEcCtD
Dutasteride—Cardiac failure—Propofol—epilepsy syndrome	0.000992	0.0045	CcSEcCtD
Dutasteride—Sexual dysfunction—Topiramate—epilepsy syndrome	0.000987	0.00448	CcSEcCtD
Dutasteride—Gynaecomastia—Clonazepam—epilepsy syndrome	0.000975	0.00442	CcSEcCtD
Dutasteride—Cardiac failure—Midazolam—epilepsy syndrome	0.00097	0.0044	CcSEcCtD
Dutasteride—Gynaecomastia—Phenytoin—epilepsy syndrome	0.000968	0.00439	CcSEcCtD
Dutasteride—Angioedema—Amobarbital—epilepsy syndrome	0.000958	0.00435	CcSEcCtD
Dutasteride—Gynaecomastia—Carbamazepine—epilepsy syndrome	0.000924	0.00419	CcSEcCtD
Dutasteride—Hyperaesthesia—Pregabalin—epilepsy syndrome	0.000914	0.00414	CcSEcCtD
Dutasteride—Cardiac failure—Diazepam—epilepsy syndrome	0.000888	0.00403	CcSEcCtD
Dutasteride—Libido decreased—Zonisamide—epilepsy syndrome	0.000885	0.00401	CcSEcCtD
Dutasteride—Disturbance in sexual arousal—Diazepam—epilepsy syndrome	0.000859	0.0039	CcSEcCtD
Dutasteride—Cardiac failure—Felbamate—epilepsy syndrome	0.000859	0.0039	CcSEcCtD
Dutasteride—Libido decreased—Clonazepam—epilepsy syndrome	0.000853	0.00387	CcSEcCtD
Dutasteride—Libido decreased—Oxcarbazepine—epilepsy syndrome	0.000843	0.00382	CcSEcCtD
Dutasteride—Cardiac failure—Zonisamide—epilepsy syndrome	0.000841	0.00381	CcSEcCtD
Dutasteride—Neoplasm malignant—Pregabalin—epilepsy syndrome	0.00084	0.00381	CcSEcCtD
Dutasteride—Hyperaesthesia—Gabapentin—epilepsy syndrome	0.000838	0.0038	CcSEcCtD
Dutasteride—Breast pain—Pregabalin—epilepsy syndrome	0.000822	0.00373	CcSEcCtD
Dutasteride—Disturbance in sexual arousal—Zonisamide—epilepsy syndrome	0.000814	0.00369	CcSEcCtD
Dutasteride—Cardiac failure—Clonazepam—epilepsy syndrome	0.00081	0.00368	CcSEcCtD
Dutasteride—Immune system disorder—Rufinamide—epilepsy syndrome	0.000802	0.00364	CcSEcCtD
Dutasteride—Cardiac failure—Oxcarbazepine—epilepsy syndrome	0.000801	0.00363	CcSEcCtD
Dutasteride—Breast disorder—Vigabatrin—epilepsy syndrome	0.000795	0.00361	CcSEcCtD
Dutasteride—Disturbance in sexual arousal—Clonazepam—epilepsy syndrome	0.000785	0.00356	CcSEcCtD
Dutasteride—Libido decreased—Lamotrigine—epilepsy syndrome	0.000781	0.00354	CcSEcCtD
Dutasteride—Mental disorder—Rufinamide—epilepsy syndrome	0.000778	0.00353	CcSEcCtD
Dutasteride—Disturbance in sexual arousal—Oxcarbazepine—epilepsy syndrome	0.000775	0.00352	CcSEcCtD
Dutasteride—Cardiac failure—Carbamazepine—epilepsy syndrome	0.000768	0.00349	CcSEcCtD
Dutasteride—Breast pain—Gabapentin—epilepsy syndrome	0.000754	0.00342	CcSEcCtD
Dutasteride—Immune system disorder—Lacosamide—epilepsy syndrome	0.000753	0.00341	CcSEcCtD
Dutasteride—Cardiac failure—Lamotrigine—epilepsy syndrome	0.000743	0.00337	CcSEcCtD
Dutasteride—Mental disorder—Lacosamide—epilepsy syndrome	0.00073	0.00331	CcSEcCtD
Dutasteride—Angioedema—Phenobarbital—epilepsy syndrome	0.000719	0.00326	CcSEcCtD
Dutasteride—Disturbance in sexual arousal—Lamotrigine—epilepsy syndrome	0.000719	0.00326	CcSEcCtD
Dutasteride—Neoplasm—Valproic Acid—epilepsy syndrome	0.000717	0.00325	CcSEcCtD
Dutasteride—Breast disorder—Clonazepam—epilepsy syndrome	0.000715	0.00324	CcSEcCtD
Dutasteride—Breast disorder—Phenytoin—epilepsy syndrome	0.00071	0.00322	CcSEcCtD
Dutasteride—Mental disorder—Clobazam—epilepsy syndrome	0.000709	0.00321	CcSEcCtD
Dutasteride—Hyperaesthesia—Topiramate—epilepsy syndrome	0.000705	0.0032	CcSEcCtD
Dutasteride—Erectile dysfunction—Vigabatrin—epilepsy syndrome	0.0007	0.00318	CcSEcCtD
Dutasteride—Erectile dysfunction—Diazepam—epilepsy syndrome	0.000689	0.00313	CcSEcCtD
Dutasteride—Angioedema—Lacosamide—epilepsy syndrome	0.000663	0.00301	CcSEcCtD
Dutasteride—Erectile dysfunction—Zonisamide—epilepsy syndrome	0.000653	0.00296	CcSEcCtD
Dutasteride—Neoplasm—Pregabalin—epilepsy syndrome	0.000648	0.00294	CcSEcCtD
Dutasteride—Gynaecomastia—Pregabalin—epilepsy syndrome	0.000642	0.00291	CcSEcCtD
Dutasteride—Breast pain—Topiramate—epilepsy syndrome	0.000634	0.00288	CcSEcCtD
Dutasteride—Hypersensitivity—Amobarbital—epilepsy syndrome	0.000631	0.00286	CcSEcCtD
Dutasteride—Erectile dysfunction—Clonazepam—epilepsy syndrome	0.00063	0.00286	CcSEcCtD
Dutasteride—Erectile dysfunction—Carbamazepine—epilepsy syndrome	0.000597	0.00271	CcSEcCtD
Dutasteride—Immune system disorder—Midazolam—epilepsy syndrome	0.000592	0.00268	CcSEcCtD
Dutasteride—Gynaecomastia—Gabapentin—epilepsy syndrome	0.000588	0.00267	CcSEcCtD
Dutasteride—Immune system disorder—Levetiracetam—epilepsy syndrome	0.000584	0.00265	CcSEcCtD
Dutasteride—Erectile dysfunction—Lamotrigine—epilepsy syndrome	0.000577	0.00262	CcSEcCtD
Dutasteride—Mental disorder—Midazolam—epilepsy syndrome	0.000574	0.0026	CcSEcCtD
Dutasteride—Mental disorder—Levetiracetam—epilepsy syndrome	0.000567	0.00257	CcSEcCtD
Dutasteride—Dizziness—Amobarbital—epilepsy syndrome	0.000566	0.00257	CcSEcCtD
Dutasteride—Libido decreased—Pregabalin—epilepsy syndrome	0.000561	0.00255	CcSEcCtD
Dutasteride—Dizziness—Primidone—epilepsy syndrome	0.000545	0.00247	CcSEcCtD
Dutasteride—Rash—Amobarbital—epilepsy syndrome	0.00054	0.00245	CcSEcCtD
Dutasteride—Dermatitis—Amobarbital—epilepsy syndrome	0.000539	0.00245	CcSEcCtD
Dutasteride—Cardiac failure—Pregabalin—epilepsy syndrome	0.000533	0.00242	CcSEcCtD
Dutasteride—Mental disorder—Vigabatrin—epilepsy syndrome	0.000533	0.00242	CcSEcCtD
Dutasteride—Angioedema—Propofol—epilepsy syndrome	0.000533	0.00242	CcSEcCtD
Dutasteride—Mental disorder—Diazepam—epilepsy syndrome	0.000525	0.00238	CcSEcCtD
Dutasteride—Breast disorder—Valproic Acid—epilepsy syndrome	0.00052	0.00236	CcSEcCtD
Dutasteride—Rash—Primidone—epilepsy syndrome	0.00052	0.00236	CcSEcCtD
Dutasteride—Dermatitis—Primidone—epilepsy syndrome	0.000519	0.00236	CcSEcCtD
Dutasteride—Disturbance in sexual arousal—Pregabalin—epilepsy syndrome	0.000516	0.00234	CcSEcCtD
Dutasteride—Libido decreased—Gabapentin—epilepsy syndrome	0.000515	0.00234	CcSEcCtD
Dutasteride—Pruritus—Trimethadione—epilepsy syndrome	0.000513	0.00233	CcSEcCtD
Dutasteride—Immune system disorder—Zonisamide—epilepsy syndrome	0.000513	0.00233	CcSEcCtD
Dutasteride—Urticaria—Phenobarbital—epilepsy syndrome	0.00051	0.00232	CcSEcCtD
Dutasteride—Neoplasm—Topiramate—epilepsy syndrome	0.0005	0.00227	CcSEcCtD
Dutasteride—Mental disorder—Zonisamide—epilepsy syndrome	0.000497	0.00226	CcSEcCtD
Dutasteride—Immune system disorder—Clonazepam—epilepsy syndrome	0.000494	0.00224	CcSEcCtD
Dutasteride—Immune system disorder—Phenytoin—epilepsy syndrome	0.000491	0.00223	CcSEcCtD
Dutasteride—Cardiac failure—Gabapentin—epilepsy syndrome	0.000489	0.00222	CcSEcCtD
Dutasteride—Immune system disorder—Oxcarbazepine—epilepsy syndrome	0.000488	0.00221	CcSEcCtD
Dutasteride—Angioedema—Vigabatrin—epilepsy syndrome	0.000484	0.0022	CcSEcCtD
Dutasteride—Mental disorder—Clonazepam—epilepsy syndrome	0.000479	0.00217	CcSEcCtD
Dutasteride—Disturbance in sexual arousal—Gabapentin—epilepsy syndrome	0.000474	0.00215	CcSEcCtD
Dutasteride—Mental disorder—Oxcarbazepine—epilepsy syndrome	0.000474	0.00215	CcSEcCtD
Dutasteride—Hypersensitivity—Phenobarbital—epilepsy syndrome	0.000473	0.00215	CcSEcCtD
Dutasteride—Breast disorder—Pregabalin—epilepsy syndrome	0.00047	0.00213	CcSEcCtD
Dutasteride—Urticaria—Lacosamide—epilepsy syndrome	0.00047	0.00213	CcSEcCtD
Dutasteride—Immune system disorder—Carbamazepine—epilepsy syndrome	0.000469	0.00213	CcSEcCtD
Dutasteride—Hypersensitivity—Rufinamide—epilepsy syndrome	0.000465	0.00211	CcSEcCtD
Dutasteride—Rash—Trimethadione—epilepsy syndrome	0.000457	0.00207	CcSEcCtD
Dutasteride—Dermatitis—Trimethadione—epilepsy syndrome	0.000457	0.00207	CcSEcCtD
Dutasteride—Urticaria—Clobazam—epilepsy syndrome	0.000457	0.00207	CcSEcCtD
Dutasteride—Mental disorder—Carbamazepine—epilepsy syndrome	0.000454	0.00206	CcSEcCtD
Dutasteride—Pruritus—Rufinamide—epilepsy syndrome	0.000446	0.00202	CcSEcCtD
Dutasteride—Mental disorder—Lamotrigine—epilepsy syndrome	0.000439	0.00199	CcSEcCtD
Dutasteride—Hypersensitivity—Lacosamide—epilepsy syndrome	0.000436	0.00198	CcSEcCtD
Dutasteride—Angioedema—Clonazepam—epilepsy syndrome	0.000435	0.00197	CcSEcCtD
Dutasteride—Libido decreased—Topiramate—epilepsy syndrome	0.000433	0.00196	CcSEcCtD
Dutasteride—Breast disorder—Gabapentin—epilepsy syndrome	0.000431	0.00196	CcSEcCtD
Dutasteride—Angioedema—Oxcarbazepine—epilepsy syndrome	0.00043	0.00195	CcSEcCtD
Dutasteride—Dizziness—Phenobarbital—epilepsy syndrome	0.000425	0.00193	CcSEcCtD
Dutasteride—Pruritus—Lacosamide—epilepsy syndrome	0.000419	0.0019	CcSEcCtD
Dutasteride—Dizziness—Rufinamide—epilepsy syndrome	0.000417	0.00189	CcSEcCtD
Dutasteride—Erectile dysfunction—Pregabalin—epilepsy syndrome	0.000414	0.00188	CcSEcCtD
Dutasteride—Angioedema—Carbamazepine—epilepsy syndrome	0.000413	0.00187	CcSEcCtD
Dutasteride—Urticaria—Acetazolamide—epilepsy syndrome	0.000407	0.00185	CcSEcCtD
Dutasteride—Pruritus—Clobazam—epilepsy syndrome	0.000407	0.00184	CcSEcCtD
Dutasteride—Rash—Phenobarbital—epilepsy syndrome	0.000405	0.00184	CcSEcCtD
Dutasteride—Dermatitis—Phenobarbital—epilepsy syndrome	0.000405	0.00184	CcSEcCtD
Dutasteride—Angioedema—Lamotrigine—epilepsy syndrome	0.000399	0.00181	CcSEcCtD
Dutasteride—Disturbance in sexual arousal—Topiramate—epilepsy syndrome	0.000398	0.00181	CcSEcCtD
Dutasteride—Rash—Rufinamide—epilepsy syndrome	0.000398	0.0018	CcSEcCtD
Dutasteride—Dermatitis—Rufinamide—epilepsy syndrome	0.000397	0.0018	CcSEcCtD
Dutasteride—Dizziness—Lacosamide—epilepsy syndrome	0.000392	0.00178	CcSEcCtD
Dutasteride—Erectile dysfunction—Gabapentin—epilepsy syndrome	0.00038	0.00172	CcSEcCtD
Dutasteride—Dizziness—Clobazam—epilepsy syndrome	0.00038	0.00172	CcSEcCtD
Dutasteride—Urticaria—Propofol—epilepsy syndrome	0.000378	0.00171	CcSEcCtD
Dutasteride—Rash—Lacosamide—epilepsy syndrome	0.000373	0.00169	CcSEcCtD
Dutasteride—Dermatitis—Lacosamide—epilepsy syndrome	0.000373	0.00169	CcSEcCtD
Dutasteride—Urticaria—Midazolam—epilepsy syndrome	0.00037	0.00168	CcSEcCtD
Dutasteride—Breast disorder—Topiramate—epilepsy syndrome	0.000363	0.00165	CcSEcCtD
Dutasteride—Rash—Clobazam—epilepsy syndrome	0.000362	0.00164	CcSEcCtD
Dutasteride—Dermatitis—Clobazam—epilepsy syndrome	0.000362	0.00164	CcSEcCtD
Dutasteride—Immune system disorder—Valproic Acid—epilepsy syndrome	0.00036	0.00163	CcSEcCtD
Dutasteride—Urticaria—Fosphenytoin—epilepsy syndrome	0.000352	0.0016	CcSEcCtD
Dutasteride—Mental disorder—Valproic Acid—epilepsy syndrome	0.000349	0.00158	CcSEcCtD
Dutasteride—Urticaria—Vigabatrin—epilepsy syndrome	0.000344	0.00156	CcSEcCtD
Dutasteride—Hypersensitivity—Midazolam—epilepsy syndrome	0.000343	0.00156	CcSEcCtD
Dutasteride—Dizziness—Acetazolamide—epilepsy syndrome	0.000339	0.00154	CcSEcCtD
Dutasteride—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.000339	0.00154	CcSEcCtD
Dutasteride—Urticaria—Diazepam—epilepsy syndrome	0.000338	0.00153	CcSEcCtD
Dutasteride—Pruritus—Propofol—epilepsy syndrome	0.000337	0.00153	CcSEcCtD
Dutasteride—Pruritus—Midazolam—epilepsy syndrome	0.000329	0.00149	CcSEcCtD
Dutasteride—Urticaria—Felbamate—epilepsy syndrome	0.000327	0.00148	CcSEcCtD
Dutasteride—Immune system disorder—Pregabalin—epilepsy syndrome	0.000325	0.00148	CcSEcCtD
Dutasteride—Pruritus—Levetiracetam—epilepsy syndrome	0.000325	0.00148	CcSEcCtD
Dutasteride—Urticaria—Zonisamide—epilepsy syndrome	0.00032	0.00145	CcSEcCtD
Dutasteride—Erectile dysfunction—Topiramate—epilepsy syndrome	0.00032	0.00145	CcSEcCtD
Dutasteride—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000319	0.00145	CcSEcCtD
Dutasteride—Angioedema—Valproic Acid—epilepsy syndrome	0.000317	0.00144	CcSEcCtD
Dutasteride—Mental disorder—Pregabalin—epilepsy syndrome	0.000316	0.00143	CcSEcCtD
Dutasteride—Dizziness—Propofol—epilepsy syndrome	0.000315	0.00143	CcSEcCtD
Dutasteride—Pruritus—Fosphenytoin—epilepsy syndrome	0.000314	0.00142	CcSEcCtD
Dutasteride—Hypersensitivity—Diazepam—epilepsy syndrome	0.000314	0.00142	CcSEcCtD
Dutasteride—Urticaria—Clonazepam—epilepsy syndrome	0.000309	0.0014	CcSEcCtD
Dutasteride—Dizziness—Midazolam—epilepsy syndrome	0.000308	0.0014	CcSEcCtD
Dutasteride—Urticaria—Phenytoin—epilepsy syndrome	0.000307	0.00139	CcSEcCtD
Dutasteride—Pruritus—Vigabatrin—epilepsy syndrome	0.000306	0.00139	CcSEcCtD
Dutasteride—Urticaria—Oxcarbazepine—epilepsy syndrome	0.000305	0.00138	CcSEcCtD
Dutasteride—Dizziness—Levetiracetam—epilepsy syndrome	0.000304	0.00138	CcSEcCtD
Dutasteride—Pruritus—Diazepam—epilepsy syndrome	0.000301	0.00137	CcSEcCtD
Dutasteride—Rash—Propofol—epilepsy syndrome	0.0003	0.00136	CcSEcCtD
Dutasteride—Dermatitis—Propofol—epilepsy syndrome	0.0003	0.00136	CcSEcCtD
Dutasteride—Immune system disorder—Gabapentin—epilepsy syndrome	0.000298	0.00135	CcSEcCtD
Dutasteride—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000297	0.00135	CcSEcCtD
Dutasteride—Rash—Midazolam—epilepsy syndrome	0.000293	0.00133	CcSEcCtD
Dutasteride—Dizziness—Fosphenytoin—epilepsy syndrome	0.000293	0.00133	CcSEcCtD
Dutasteride—Dermatitis—Midazolam—epilepsy syndrome	0.000293	0.00133	CcSEcCtD
Dutasteride—Urticaria—Carbamazepine—epilepsy syndrome	0.000293	0.00133	CcSEcCtD
Dutasteride—Pruritus—Felbamate—epilepsy syndrome	0.000292	0.00132	CcSEcCtD
Dutasteride—SRD5A1—forebrain—epilepsy syndrome	0.00029	0.242	CbGeAlD
Dutasteride—Rash—Levetiracetam—epilepsy syndrome	0.00029	0.00131	CcSEcCtD
Dutasteride—Dermatitis—Levetiracetam—epilepsy syndrome	0.00029	0.00131	CcSEcCtD
Dutasteride—Mental disorder—Gabapentin—epilepsy syndrome	0.000289	0.00131	CcSEcCtD
Dutasteride—Angioedema—Pregabalin—epilepsy syndrome	0.000286	0.0013	CcSEcCtD
Dutasteride—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000286	0.0013	CcSEcCtD
Dutasteride—Dizziness—Vigabatrin—epilepsy syndrome	0.000286	0.0013	CcSEcCtD
Dutasteride—Pruritus—Zonisamide—epilepsy syndrome	0.000285	0.00129	CcSEcCtD
Dutasteride—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000284	0.00129	CcSEcCtD
Dutasteride—Urticaria—Lamotrigine—epilepsy syndrome	0.000283	0.00128	CcSEcCtD
Dutasteride—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000283	0.00128	CcSEcCtD
Dutasteride—Dizziness—Diazepam—epilepsy syndrome	0.000282	0.00128	CcSEcCtD
Dutasteride—Rash—Fosphenytoin—epilepsy syndrome	0.00028	0.00127	CcSEcCtD
Dutasteride—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000279	0.00127	CcSEcCtD
Dutasteride—Pruritus—Clonazepam—epilepsy syndrome	0.000275	0.00125	CcSEcCtD
Dutasteride—Pruritus—Phenytoin—epilepsy syndrome	0.000273	0.00124	CcSEcCtD
Dutasteride—Rash—Vigabatrin—epilepsy syndrome	0.000273	0.00124	CcSEcCtD
Dutasteride—Dizziness—Felbamate—epilepsy syndrome	0.000272	0.00124	CcSEcCtD
Dutasteride—Dermatitis—Vigabatrin—epilepsy syndrome	0.000272	0.00124	CcSEcCtD
Dutasteride—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000272	0.00123	CcSEcCtD
Dutasteride—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000272	0.00123	CcSEcCtD
Dutasteride—Rash—Diazepam—epilepsy syndrome	0.000268	0.00122	CcSEcCtD
Dutasteride—Dermatitis—Diazepam—epilepsy syndrome	0.000268	0.00122	CcSEcCtD
Dutasteride—SRD5A1—telencephalon—epilepsy syndrome	0.000267	0.223	CbGeAlD
Dutasteride—Dizziness—Zonisamide—epilepsy syndrome	0.000267	0.00121	CcSEcCtD
Dutasteride—Angioedema—Gabapentin—epilepsy syndrome	0.000263	0.00119	CcSEcCtD
Dutasteride—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000262	0.00119	CcSEcCtD
Dutasteride—Pruritus—Carbamazepine—epilepsy syndrome	0.000261	0.00118	CcSEcCtD
Dutasteride—Rash—Felbamate—epilepsy syndrome	0.00026	0.00118	CcSEcCtD
Dutasteride—Dermatitis—Felbamate—epilepsy syndrome	0.00026	0.00118	CcSEcCtD
Dutasteride—Dizziness—Clonazepam—epilepsy syndrome	0.000257	0.00117	CcSEcCtD
Dutasteride—Dizziness—Phenytoin—epilepsy syndrome	0.000255	0.00116	CcSEcCtD
Dutasteride—Rash—Zonisamide—epilepsy syndrome	0.000254	0.00115	CcSEcCtD
Dutasteride—Dermatitis—Zonisamide—epilepsy syndrome	0.000254	0.00115	CcSEcCtD
Dutasteride—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000254	0.00115	CcSEcCtD
Dutasteride—Pruritus—Lamotrigine—epilepsy syndrome	0.000252	0.00114	CcSEcCtD
Dutasteride—Immune system disorder—Topiramate—epilepsy syndrome	0.000251	0.00114	CcSEcCtD
Dutasteride—CYP3A5—Constitutive Androstane Receptor Pathway—ABCB1—epilepsy syndrome	0.000248	0.00355	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—PPP1R3C—epilepsy syndrome	0.000247	0.00354	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—PPP1R3C—epilepsy syndrome	0.000247	0.00354	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—GBE1—epilepsy syndrome	0.000247	0.00354	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—GBE1—epilepsy syndrome	0.000247	0.00354	CbGpPWpGaD
Dutasteride—Rash—Clonazepam—epilepsy syndrome	0.000245	0.00111	CcSEcCtD
Dutasteride—Dermatitis—Clonazepam—epilepsy syndrome	0.000245	0.00111	CcSEcCtD
Dutasteride—Dizziness—Carbamazepine—epilepsy syndrome	0.000244	0.00111	CcSEcCtD
Dutasteride—Rash—Phenytoin—epilepsy syndrome	0.000243	0.0011	CcSEcCtD
Dutasteride—Mental disorder—Topiramate—epilepsy syndrome	0.000243	0.0011	CcSEcCtD
Dutasteride—Dermatitis—Phenytoin—epilepsy syndrome	0.000243	0.0011	CcSEcCtD
Dutasteride—Rash—Oxcarbazepine—epilepsy syndrome	0.000242	0.0011	CcSEcCtD
Dutasteride—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000242	0.0011	CcSEcCtD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	0.000242	0.00346	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	0.000242	0.00346	CbGpPWpGaD
Dutasteride—Dizziness—Lamotrigine—epilepsy syndrome	0.000236	0.00107	CcSEcCtD
Dutasteride—CYP3A4—Xenobiotics—CYP2D6—epilepsy syndrome	0.000235	0.00337	CbGpPWpGaD
Dutasteride—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2C19—epilepsy syndrome	0.000234	0.00335	CbGpPWpGaD
Dutasteride—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	0.000233	0.00333	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—ASAH1—epilepsy syndrome	0.000233	0.00333	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—ASAH1—epilepsy syndrome	0.000233	0.00333	CbGpPWpGaD
Dutasteride—Rash—Carbamazepine—epilepsy syndrome	0.000232	0.00105	CcSEcCtD
Dutasteride—Dermatitis—Carbamazepine—epilepsy syndrome	0.000232	0.00105	CcSEcCtD
Dutasteride—CYP3A5—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	0.000231	0.00331	CbGpPWpGaD
Dutasteride—CYP3A5—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	0.00023	0.00329	CbGpPWpGaD
Dutasteride—CYP3A4—Tamoxifen metabolism—CYP2D6—epilepsy syndrome	0.000226	0.00324	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—STXBP1—epilepsy syndrome	0.000226	0.00324	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—STXBP1—epilepsy syndrome	0.000226	0.00324	CbGpPWpGaD
Dutasteride—Urticaria—Valproic Acid—epilepsy syndrome	0.000225	0.00102	CcSEcCtD
Dutasteride—Rash—Lamotrigine—epilepsy syndrome	0.000225	0.00102	CcSEcCtD
Dutasteride—Dermatitis—Lamotrigine—epilepsy syndrome	0.000224	0.00102	CcSEcCtD
Dutasteride—SRD5A1—Metabolism—ALAD—epilepsy syndrome	0.00022	0.00315	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—NT5E—epilepsy syndrome	0.00022	0.00315	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—NT5E—epilepsy syndrome	0.00022	0.00315	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—ALAD—epilepsy syndrome	0.00022	0.00315	CbGpPWpGaD
Dutasteride—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—epilepsy syndrome	0.000217	0.00311	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—CACNA1A—epilepsy syndrome	0.00021	0.00301	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—CACNA1A—epilepsy syndrome	0.00021	0.00301	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—ALDH7A1—epilepsy syndrome	0.00021	0.00301	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—ALDH7A1—epilepsy syndrome	0.00021	0.00301	CbGpPWpGaD
Dutasteride—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2D6—epilepsy syndrome	0.00021	0.00301	CbGpPWpGaD
Dutasteride—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000209	0.000946	CcSEcCtD
Dutasteride—CYP3A5—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	0.000207	0.00297	CbGpPWpGaD
Dutasteride—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—epilepsy syndrome	0.000207	0.00296	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—ST3GAL3—epilepsy syndrome	0.000206	0.00295	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—ST3GAL3—epilepsy syndrome	0.000206	0.00295	CbGpPWpGaD
Dutasteride—Urticaria—Pregabalin—epilepsy syndrome	0.000203	0.000922	CcSEcCtD
Dutasteride—SRD5A1—Metabolism—ADSL—epilepsy syndrome	0.000202	0.00289	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—ADSL—epilepsy syndrome	0.000202	0.00289	CbGpPWpGaD
Dutasteride—Pruritus—Valproic Acid—epilepsy syndrome	0.0002	0.000908	CcSEcCtD
Dutasteride—SRD5A1—Metabolism—GLUL—epilepsy syndrome	0.000198	0.00283	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—GLUL—epilepsy syndrome	0.000198	0.00283	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—CACNA1D—epilepsy syndrome	0.000194	0.00278	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—CACNA1D—epilepsy syndrome	0.000194	0.00278	CbGpPWpGaD
Dutasteride—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—epilepsy syndrome	0.000191	0.00274	CbGpPWpGaD
Dutasteride—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—epilepsy syndrome	0.000191	0.00273	CbGpPWpGaD
Dutasteride—CYP3A4—Tryptophan metabolism—UBE3A—epilepsy syndrome	0.00019	0.00272	CbGpPWpGaD
Dutasteride—CYP3A5—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	0.00019	0.00272	CbGpPWpGaD
Dutasteride—CYP3A5—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	0.000189	0.0027	CbGpPWpGaD
Dutasteride—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000189	0.000855	CcSEcCtD
Dutasteride—Dizziness—Valproic Acid—epilepsy syndrome	0.000187	0.000849	CcSEcCtD
Dutasteride—Urticaria—Gabapentin—epilepsy syndrome	0.000186	0.000846	CcSEcCtD
Dutasteride—SRD5A1—Metabolism—TXNRD1—epilepsy syndrome	0.000182	0.0026	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—TXNRD1—epilepsy syndrome	0.000182	0.0026	CbGpPWpGaD
Dutasteride—Pruritus—Pregabalin—epilepsy syndrome	0.000181	0.000821	CcSEcCtD
Dutasteride—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C19—epilepsy syndrome	0.00018	0.00258	CbGpPWpGaD
Dutasteride—Rash—Valproic Acid—epilepsy syndrome	0.000178	0.000809	CcSEcCtD
Dutasteride—Dermatitis—Valproic Acid—epilepsy syndrome	0.000178	0.000809	CcSEcCtD
Dutasteride—SRD5A2—Metabolism—AQP1—epilepsy syndrome	0.000176	0.00252	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—AQP1—epilepsy syndrome	0.000176	0.00252	CbGpPWpGaD
Dutasteride—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000173	0.000784	CcSEcCtD
Dutasteride—CYP3A5—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	0.00017	0.00244	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	0.000169	0.00242	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	0.000169	0.00242	CbGpPWpGaD
Dutasteride—Dizziness—Pregabalin—epilepsy syndrome	0.000169	0.000768	CcSEcCtD
Dutasteride—SRD5A1—head—epilepsy syndrome	0.000166	0.139	CbGeAlD
Dutasteride—Pruritus—Gabapentin—epilepsy syndrome	0.000166	0.000753	CcSEcCtD
Dutasteride—Rash—Pregabalin—epilepsy syndrome	0.000161	0.000732	CcSEcCtD
Dutasteride—Dermatitis—Pregabalin—epilepsy syndrome	0.000161	0.000731	CcSEcCtD
Dutasteride—SRD5A1—Metabolism—KCNJ11—epilepsy syndrome	0.000159	0.00228	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—KCNJ11—epilepsy syndrome	0.000159	0.00228	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—CHRM3—epilepsy syndrome	0.000159	0.00228	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—CHRM3—epilepsy syndrome	0.000159	0.00228	CbGpPWpGaD
Dutasteride—SRD5A1—nervous system—epilepsy syndrome	0.000157	0.132	CbGeAlD
Dutasteride—Urticaria—Topiramate—epilepsy syndrome	0.000157	0.000711	CcSEcCtD
Dutasteride—Dizziness—Gabapentin—epilepsy syndrome	0.000155	0.000704	CcSEcCtD
Dutasteride—SRD5A1—central nervous system—epilepsy syndrome	0.000152	0.127	CbGeAlD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	0.000148	0.00212	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	0.000148	0.00212	CbGpPWpGaD
Dutasteride—Rash—Gabapentin—epilepsy syndrome	0.000148	0.000671	CcSEcCtD
Dutasteride—Dermatitis—Gabapentin—epilepsy syndrome	0.000148	0.00067	CcSEcCtD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	0.000145	0.00208	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	0.000145	0.00208	CbGpPWpGaD
Dutasteride—Hypersensitivity—Topiramate—epilepsy syndrome	0.000145	0.00066	CcSEcCtD
Dutasteride—CYP3A4—Metapathway biotransformation—KCNAB2—epilepsy syndrome	0.00014	0.00201	CbGpPWpGaD
Dutasteride—Pruritus—Topiramate—epilepsy syndrome	0.00014	0.000634	CcSEcCtD
Dutasteride—Dizziness—Topiramate—epilepsy syndrome	0.000131	0.000592	CcSEcCtD
Dutasteride—SRD5A2—Metabolism—ABCG2—epilepsy syndrome	0.00013	0.00186	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—ABCG2—epilepsy syndrome	0.00013	0.00186	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—CYP2C19—epilepsy syndrome	0.000127	0.00181	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—CYP2C19—epilepsy syndrome	0.000127	0.00181	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—CYP11A1—epilepsy syndrome	0.000126	0.0018	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—CYP11A1—epilepsy syndrome	0.000126	0.0018	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	0.000125	0.00179	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	0.000125	0.00179	CbGpPWpGaD
Dutasteride—Rash—Topiramate—epilepsy syndrome	0.000124	0.000565	CcSEcCtD
Dutasteride—Dermatitis—Topiramate—epilepsy syndrome	0.000124	0.000564	CcSEcCtD
Dutasteride—SRD5A1—brain—epilepsy syndrome	0.00012	0.101	CbGeAlD
Dutasteride—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—epilepsy syndrome	0.000115	0.00165	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	0.000114	0.00163	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	0.000114	0.00163	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—CYP2D6—epilepsy syndrome	0.000114	0.00163	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—CYP2D6—epilepsy syndrome	0.000114	0.00163	CbGpPWpGaD
Dutasteride—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—epilepsy syndrome	0.00011	0.00157	CbGpPWpGaD
Dutasteride—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—epilepsy syndrome	0.00011	0.00157	CbGpPWpGaD
Dutasteride—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C19—epilepsy syndrome	0.000109	0.00156	CbGpPWpGaD
Dutasteride—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	0.000108	0.00155	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—ADRA2A—epilepsy syndrome	0.000108	0.00155	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—ADRA2A—epilepsy syndrome	0.000108	0.00155	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—BCHE—epilepsy syndrome	0.000108	0.00154	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—BCHE—epilepsy syndrome	0.000108	0.00154	CbGpPWpGaD
Dutasteride—CYP3A4—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	0.000108	0.00154	CbGpPWpGaD
Dutasteride—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	0.000107	0.00153	CbGpPWpGaD
Dutasteride—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	0.000103	0.00147	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—SLC2A1—epilepsy syndrome	0.000103	0.00147	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—SLC2A1—epilepsy syndrome	0.000103	0.00147	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—PLCB1—epilepsy syndrome	0.000102	0.00145	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—PLCB1—epilepsy syndrome	0.000102	0.00145	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—TH—epilepsy syndrome	0.000101	0.00145	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—TH—epilepsy syndrome	0.000101	0.00145	CbGpPWpGaD
Dutasteride—CYP3A5—Biological oxidations—CYP2C19—epilepsy syndrome	0.000101	0.00144	CbGpPWpGaD
Dutasteride—CYP3A5—Biological oxidations—CYP11A1—epilepsy syndrome	0.0001	0.00144	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	9.97e-05	0.00143	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	9.97e-05	0.00143	CbGpPWpGaD
Dutasteride—CYP3A5—Metapathway biotransformation—CYP2C19—epilepsy syndrome	9.95e-05	0.00142	CbGpPWpGaD
Dutasteride—CYP3A5—Metapathway biotransformation—CYP11A1—epilepsy syndrome	9.89e-05	0.00142	CbGpPWpGaD
Dutasteride—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—epilepsy syndrome	9.77e-05	0.0014	CbGpPWpGaD
Dutasteride—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	9.65e-05	0.00138	CbGpPWpGaD
Dutasteride—CYP3A5—Biological oxidations—CYP2D6—epilepsy syndrome	9.05e-05	0.0013	CbGpPWpGaD
Dutasteride—CYP3A5—Metapathway biotransformation—CYP2D6—epilepsy syndrome	8.93e-05	0.00128	CbGpPWpGaD
Dutasteride—CYP3A4—Tryptophan metabolism—CAT—epilepsy syndrome	8.87e-05	0.00127	CbGpPWpGaD
Dutasteride—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	8.83e-05	0.00126	CbGpPWpGaD
Dutasteride—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	8.78e-05	0.00126	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—HMOX1—epilepsy syndrome	8.45e-05	0.00121	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—HMOX1—epilepsy syndrome	8.45e-05	0.00121	CbGpPWpGaD
Dutasteride—CYP3A5—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	8.35e-05	0.00119	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—CAT—epilepsy syndrome	8.34e-05	0.00119	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—CAT—epilepsy syndrome	8.34e-05	0.00119	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—ABCB1—epilepsy syndrome	8.11e-05	0.00116	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—ABCB1—epilepsy syndrome	8.11e-05	0.00116	CbGpPWpGaD
Dutasteride—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	7.92e-05	0.00113	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—GPX1—epilepsy syndrome	7.54e-05	0.00108	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—GPX1—epilepsy syndrome	7.54e-05	0.00108	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—CA13—epilepsy syndrome	6.9e-05	0.000988	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—AGT—epilepsy syndrome	6.61e-05	0.000946	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—AGT—epilepsy syndrome	6.61e-05	0.000946	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—APOE—epilepsy syndrome	6.48e-05	0.000927	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—APOE—epilepsy syndrome	6.48e-05	0.000927	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—POMC—epilepsy syndrome	5.56e-05	0.000796	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—POMC—epilepsy syndrome	5.56e-05	0.000796	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—GLUD1—epilepsy syndrome	5.23e-05	0.000749	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—CERS1—epilepsy syndrome	5.23e-05	0.000749	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PDXK—epilepsy syndrome	5.23e-05	0.000749	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—FAR1—epilepsy syndrome	5.23e-05	0.000749	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ADK—epilepsy syndrome	5.23e-05	0.000749	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—L2HGDH—epilepsy syndrome	5.23e-05	0.000749	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—ALB—epilepsy syndrome	5.07e-05	0.000726	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—ALB—epilepsy syndrome	5.07e-05	0.000726	CbGpPWpGaD
Dutasteride—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	4.79e-05	0.000685	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PNPO—epilepsy syndrome	4.79e-05	0.000685	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—GAMT—epilepsy syndrome	4.79e-05	0.000685	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—NHLRC1—epilepsy syndrome	4.79e-05	0.000685	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—EPM2A—epilepsy syndrome	4.79e-05	0.000685	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	4.69e-05	0.000671	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	4.66e-05	0.000667	CbGpPWpGaD
Dutasteride—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	4.63e-05	0.000662	CbGpPWpGaD
Dutasteride—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	4.6e-05	0.000658	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—CA4—epilepsy syndrome	4.45e-05	0.000637	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—QDPR—epilepsy syndrome	4.45e-05	0.000637	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—PTGS2—epilepsy syndrome	4.44e-05	0.000635	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—PTGS2—epilepsy syndrome	4.44e-05	0.000635	CbGpPWpGaD
Dutasteride—CYP3A5—Biological oxidations—POMC—epilepsy syndrome	4.44e-05	0.000635	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	4.21e-05	0.000602	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—COX3—epilepsy syndrome	4.18e-05	0.000599	CbGpPWpGaD
Dutasteride—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	4.15e-05	0.000594	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—CACNA2D2—epilepsy syndrome	3.97e-05	0.000567	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—SLCO1A2—epilepsy syndrome	3.97e-05	0.000567	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—KCNB1—epilepsy syndrome	3.97e-05	0.000567	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PFKL—epilepsy syndrome	3.97e-05	0.000567	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—SLC6A8—epilepsy syndrome	3.97e-05	0.000567	CbGpPWpGaD
Dutasteride—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	3.88e-05	0.000555	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—NEU1—epilepsy syndrome	3.63e-05	0.000519	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ATIC—epilepsy syndrome	3.63e-05	0.000519	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—UPB1—epilepsy syndrome	3.63e-05	0.000519	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—HSD17B4—epilepsy syndrome	3.49e-05	0.0005	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—GBE1—epilepsy syndrome	3.37e-05	0.000482	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PPP1R3C—epilepsy syndrome	3.37e-05	0.000482	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—CA13—epilepsy syndrome	3.21e-05	0.000459	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ASAH1—epilepsy syndrome	3.17e-05	0.000454	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—STXBP1—epilepsy syndrome	3.08e-05	0.000441	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—NT5E—epilepsy syndrome	3.01e-05	0.00043	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ALAD—epilepsy syndrome	3.01e-05	0.00043	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—CACNA1A—epilepsy syndrome	2.87e-05	0.00041	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ALDH7A1—epilepsy syndrome	2.87e-05	0.00041	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ST3GAL3—epilepsy syndrome	2.81e-05	0.000401	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ADSL—epilepsy syndrome	2.75e-05	0.000393	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—GLUL—epilepsy syndrome	2.7e-05	0.000386	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—CACNA1D—epilepsy syndrome	2.65e-05	0.000379	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—TXNRD1—epilepsy syndrome	2.47e-05	0.000354	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—FAR1—epilepsy syndrome	2.43e-05	0.000348	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—CERS1—epilepsy syndrome	2.43e-05	0.000348	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ADK—epilepsy syndrome	2.43e-05	0.000348	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	2.43e-05	0.000348	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PDXK—epilepsy syndrome	2.43e-05	0.000348	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	2.43e-05	0.000348	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—AQP1—epilepsy syndrome	2.4e-05	0.000344	CbGpPWpGaD
Dutasteride—CYP3A4—nervous system—epilepsy syndrome	2.25e-05	0.0188	CbGeAlD
Dutasteride—SRD5A2—Metabolism—AKT1—epilepsy syndrome	2.23e-05	0.000319	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—AKT1—epilepsy syndrome	2.23e-05	0.000319	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PNPO—epilepsy syndrome	2.22e-05	0.000318	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	2.22e-05	0.000318	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—GAMT—epilepsy syndrome	2.22e-05	0.000318	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	2.22e-05	0.000318	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—KCNJ11—epilepsy syndrome	2.17e-05	0.000311	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—CHRM3—epilepsy syndrome	2.17e-05	0.000311	CbGpPWpGaD
Dutasteride—CYP3A4—central nervous system—epilepsy syndrome	2.17e-05	0.0181	CbGeAlD
Dutasteride—CYP3A4—Metabolism—QDPR—epilepsy syndrome	2.07e-05	0.000296	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—CA4—epilepsy syndrome	2.07e-05	0.000296	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	2.06e-05	0.000295	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—COX3—epilepsy syndrome	1.94e-05	0.000278	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	1.84e-05	0.000264	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	1.84e-05	0.000264	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	1.84e-05	0.000264	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PFKL—epilepsy syndrome	1.84e-05	0.000264	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	1.84e-05	0.000264	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ABCG2—epilepsy syndrome	1.77e-05	0.000253	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—CYP2C19—epilepsy syndrome	1.73e-05	0.000247	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—CYP11A1—epilepsy syndrome	1.72e-05	0.000245	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ATIC—epilepsy syndrome	1.69e-05	0.000241	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—NEU1—epilepsy syndrome	1.69e-05	0.000241	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—UPB1—epilepsy syndrome	1.69e-05	0.000241	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	1.62e-05	0.000232	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—GBE1—epilepsy syndrome	1.57e-05	0.000224	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	1.57e-05	0.000224	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—CYP2D6—epilepsy syndrome	1.55e-05	0.000222	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	1.47e-05	0.000211	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ADRA2A—epilepsy syndrome	1.47e-05	0.000211	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—BCHE—epilepsy syndrome	1.47e-05	0.00021	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	1.43e-05	0.000205	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—SLC2A1—epilepsy syndrome	1.4e-05	0.0002	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—NT5E—epilepsy syndrome	1.4e-05	0.0002	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ALAD—epilepsy syndrome	1.4e-05	0.0002	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PLCB1—epilepsy syndrome	1.38e-05	0.000198	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—TH—epilepsy syndrome	1.38e-05	0.000197	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	1.33e-05	0.000191	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	1.33e-05	0.000191	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	1.3e-05	0.000187	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ADSL—epilepsy syndrome	1.28e-05	0.000183	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—GLUL—epilepsy syndrome	1.25e-05	0.000179	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	1.23e-05	0.000176	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	1.15e-05	0.000165	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	1.15e-05	0.000165	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—CAT—epilepsy syndrome	1.14e-05	0.000163	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—AQP1—epilepsy syndrome	1.12e-05	0.00016	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	1.11e-05	0.000158	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—GPX1—epilepsy syndrome	1.03e-05	0.000147	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	1.01e-05	0.000145	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	1.01e-05	0.000145	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—AGT—epilepsy syndrome	9.01e-06	0.000129	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—APOE—epilepsy syndrome	8.83e-06	0.000126	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	8.23e-06	0.000118	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	8.02e-06	0.000115	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	7.98e-06	0.000114	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—POMC—epilepsy syndrome	7.59e-06	0.000109	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	7.2e-06	0.000103	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ALB—epilepsy syndrome	6.92e-06	9.9e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	6.85e-06	9.8e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—BCHE—epilepsy syndrome	6.82e-06	9.76e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	6.51e-06	9.31e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	6.44e-06	9.21e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—TH—epilepsy syndrome	6.42e-06	9.18e-05	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	6.05e-06	8.66e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	5.35e-06	7.66e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—CAT—epilepsy syndrome	5.28e-06	7.56e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	5.14e-06	7.35e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—GPX1—epilepsy syndrome	4.78e-06	6.84e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—AGT—epilepsy syndrome	4.19e-06	5.99e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—APOE—epilepsy syndrome	4.1e-06	5.87e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—POMC—epilepsy syndrome	3.53e-06	5.05e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ALB—epilepsy syndrome	3.21e-06	4.6e-05	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—AKT1—epilepsy syndrome	3.04e-06	4.35e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	2.81e-06	4.02e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.41e-06	2.02e-05	CbGpPWpGaD
